CIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets

Tsai, Shengdar Q, Nguyen, Nhu T, Malagon-Lopez, Jose, Topkar, Ved V, Aryee, Martin J, Joung, J Keith·2017·Nature Methods
DOI 10.1038/nmeth.4278

Cited by (816)

Items 701–800 of 816

  1. Validation of a Novel Double Control Quantitative Copy Number PCR Method to Quantify Off-Target Transgene Integration after CRISPR-Induced DNA Modification
    Brit‐Maren M. Schjeide, Maren Schenke, Bettina Seeger, Gerhard P. Püschel · 2022 · Methods and Protocols
  2. An atypical CRISPR-Cas locus in Symbiobacterium thermophilum flanked by a transposase, a reverse transcriptase, the endonuclease MutS2 and a putative Cas9-like protein
    Sandeep Chakraborty · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Getting Into the Rhythm With CRISPR
    Thierry VandenDriessche, Marinee Chuah · 2018 · Circulation Research
  4. Validation and Long-Term Follow Up of CD33 Off-Targets Predicted In Vitro and In Silico Using Error-Corrected Sequencing in Rhesus Macaques
    Aisha A. Aljanahi, Cícera Regina Lazzarotto, Shirley Chen, Tae–Hoon Shin, Stefan Cordes, Isabel Jabara, Yifan Zhou, David J. Young, Byung‐Chul Lee, Kyung–Rok Yu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Genomic Characterization of Sickle Cell Mouse Models for Therapeutic Genome Editing Applications
    Kaitly J. Woodard · 2021
  6. Specificity of CRISPR‐Cas9 Gene Editing
    Niklas Selfjord, Alexandra Madsen, Pınar Akçakaya · 2022 · Wiley eBooks
  7. Diminished adherence of Biomphalaria glabrata embryonic cell line to sporocysts of Schistosoma mansoni following programmed knockout of the allograft inflammatory factor
    Fernanda Sales Coelho, Rutchanee Rodpai, André Miller, Shannon E. Karinshak, Victoria H. Mann, Omar dos Santos Carvalho, Roberta Lima Cladeira, Marina de Moraes Mourão, Paul J. Brindley, Wannaporn Ittiprasert · 2020 · Research Square
  8. Target-matched increased fidelity SpCas9 variants can edit any target without genome-wide off-target effects
    Péter István Kulcsár, András Tálas, Zoltán Ligeti, Eszter Tóth, Zsófia Rakvács, Vanessza Laura Végi, Sarah Laura Krausz, Krisztina Huszár, Ervin Welker · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Detection and Quantification of Genome Editing Events in Preclinical and Clinical Studies
    Marina Falaleeva, Shengdar Q. Tsai, Kathleen E. Meyer, Yanmei Lu · 2024 · Wiley eBooks
  10. Towards understanding maize domestication: Genetic transformation and genomic editing of teosinte (Zea mays ssp. parviglumis)
    Jacob D. Zobrist · 2023
  11. A one-dimensional semaglutide-GLP-1R-based mini static GIBAC
    Wei Li · 2024 · Preprints.org
  12. Preventing Large Deletions and Chromosome Loss in Engineered Human Primary T Cells by CasPlus with Optimized Guide RNAs
    Qiaoyan Yang, Jonathan S. Abebe, Michelle Mai, Colin T. Konishi, Orrin Devinsky, Chengzu Long · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. DeepEmbCas9: Cas9 coevolution and sgRNA structural information for CRISPR-Cas9 cleavage activity prediction
    Jeffrey Kelvin Mak, Péter Mináry · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  14. A mechanistic free-energy model explains and predicts sequence- and context-dependent CRISPR–Cas9 activity
    Hidde S. Offerhaus, Ieva Jaskovikaitė, Stephen K. Jones, Martin Depken · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  15. High-throughput in vitro specificity profiling of natural and high-fidelity CRISPR-Cas9 variants
    Karthik Murugan, Arun Somwarpet Seetharam, Andrew Josef Severin, Dipali G. Sashital · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Genomeditierung in der Zell- und Gentherapie
    Jan Pruszak, Maximilian Müller, Saskia König, Toni Cathomen · 2017 · Transfusionsmedizin
  17. The fourth annual BRDS on genome editing and silencing for precision medicines
    Amit Chaudhary, Rajan Sharma Bhattarai, Ram I. Mahato · 2017 · Drug Delivery and Translational Research
  18. Lessons From Using Genome Editing to Create a Faithful Model of a Novel Congenital Anemia
    Xiaoli Mi · 2018 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
  19. Rapid Proteomic Screen of CRISPR Experiment Outcome by Data Independent Acquisition Mass Spectrometry: A Case Study for HMGN1
    Martin Mehnert, Wenxue Li, Chongde Wu, Barbora Šalovská, Yansheng Liu · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Target DNA mutagenesis-based fluorescence assessment of off-target activity of the CRISPR-Cas9 system
    Dan Wang, Cuili Niu, Jingxin Han, Dejun Ma, Zhen Xi · 2019 · RSC Advances
  21. CRISPR Jump-Starts Gene Therapy
    MaryAnn Labant · 2019 · Genetic Engineering & Biotechnology News
  22. Towards best-practice approaches for CRISPR/Cas9 gene engineering
    Claude Van Campenhout, Pauline Cabochette, Anne-Clémence Veillard, Miklós Laczik, Agnieszka Zelisko-Schmidt, Céline Sabatel, Maxime Dhainaut, Benoît Vanhollebeke, Cyril Gueydan, Véronique Kruys · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  23. New Genetic Approaches to Treating Diseases of the Skin
    Stephen L. Hart, Amy Walker · 2019 · Harper's Textbook of Pediatric Dermatology
  24. Mapping of DNA damage genome-wide at nucleotide resolution by circle-damage-sequencing
    Seung‐Gi Jin, Dean Pettinga, Jennifer S. Johnson, Gerd P. Pfeifer · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Application of genome editing technology in human gene therapy
    Kohnosuke Mitani · 2020 · Translational and Regulatory Sciences
  26. Development of CRISPR/Cas-mediated gene editing in the retina
    FengJiu Li · 2020 · UTAS Research Repository
  27. Current Capabilities, Precision, and Risks of Genome Editing Techniques in Agricultural Systems
    Morgan Carter · 2020 · Preprints.org
  28. CRISPR/Cas9 technologies to manipulate human induced pluripotent stem cells
    Hyunsoo Jang, Jihoon Moon, Namshik Kim, Ki‐Jun Yoon · 2021 · Elsevier eBooks
  29. Modelling and genetic correction of liver genetic diseases
    Mihaela Zabulica · 2021 · Figshare
  30. Genetic causes and stem-cell-based therapeutic strategies in neuromuscular diseases
    Le Guo · 2021
  31. Ultra-deep sequencing reveals no evidence of oncogenic mutations or enrichment by ex vivo CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    M. Kyle Cromer, Valentin V. Barsan, Erich B. Jaeger, Mengchi Wang, Jessica P. Hampton, Feng Chen, Drew Kennedy, Irina Khrebtukova, Ana Granat, Tiffany Truong et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Brisbane River Expressways as Landscape Urbanism
    Glenn S. Thomas · 2001
  33. Crispr-Embedding: CRISPR/Cas9 Off-Target Activity Prediction Using DNA k-Mer Embedding
    Swakkhar Shatabda, Anika Tahsin, Zarin Tasnim, Muneera Chowdhury, Kangkhita Hassin, Galib Hossain Meraz, Kazi Farzana Aziz · 2022 · SSRN Electronic Journal
  34. Diminished adherence of Biomphalaria glabrata embryonic cell line to sporocysts of Schistosoma mansoni following programmed knockout of the allograft inflammatory factor
    Fernanda Sales Coelho, Rutchanee Rodpai, André Miller, Shannon E. Karinshak, Victoria H. Mann, Omar dos Santos Carvalho, Roberta Lima Cladeira, Marina de Moraes Mourão, Paul J. Brindley, Wannaporn Ittiprasert · 2020 · Research Square
  35. Diminished Adherence of Biomphalaria Glabrata Embryonic Cell Line to Sporocysts of Schistosoma Mansoni Following Programmed Knockout of the Allograft Inflammatory Factor
    Fernanda Sales Coelho, Rutchanee Rodpai, André Miller, Shannon E. Karinshak, Victoria H. Mann, Omar dos Santos Carvalho, Roberta Lima Cladeira, Marina de Moraes Mourão, Paul J. Brindley, Wannaporn Ittiprasert · 2020 · Research Square
  36. Faculty Opinions recommendation of In vivo CRISPR editing with no detectable genome-wide off-target mutations.
    Kevin Yuk-Lap Yip · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  37. Review of Cell and Molecular Biology
    Kay T. Elder, Brian Dale · 2019 · Cambridge University Press eBooks
  38. Molecular Mechanisms of Type II CRISPR ‐ Cas Systems
    Tautvydas Karvelis, Virginijus Šikšnys · 2022 · Wiley eBooks
  39. Plant Genome Editing
    Naoki Wada, Yuriko Osakabe, Keishi Osakabe · 2022 · CABI eBooks
  40. Functional Screening in human HSPCs identifies optimized protein-based enhancers of Homology Directed Repair
    Juan A. Pérez-Bermejo, Oghene Efagene, William M. Matern, Jeffrey K. Holden, Shaheen Kabir, Glen M. Chew, Gaia Andreoletti, Eniola Catton, Craig L. Ennis, Angelica Garcia et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Understanding genetic heterogeneity in gene-edited hematopoietic stem cell products
    H. Becker, Satoshi Yamazaki · 2023 · Experimental Hematology
  42. Gene Editing Approaches for Haematological Disorders
    Samuele Ferrari, Daniele Canarutto · 2024 · Elsevier eBooks
  43. Molecular Genetic Therapies in the Muscular Dystrophies
    Stefan Nicolau, Kevin M. Flanigan · 2023 · Current clinical neurology
  44. Inter-molecular Binding Affinity Synthetic Data Augmentation Transforms the Landscape of Computational Biomolecule Design and Discovery
    Wei Li · 2024 · Preprints.org
  45. Base editing of the GLB1 gene is therapeutic in GM1 gangliosidosis patient-derived cells
    Allisandra K. Rha, Shih‐hsin Kan, Perla Andrade-Heckman, Chloe L. Christensen, Jerry F. Harb, Raymond Wang · 2024 · Molecular Genetics and Metabolism
  46. Systematic empirical evaluation of individual base editing targets: validating therapeutic targets in USH2A and comparison of methods
    Yuki Tachida, Kannan Vrindavan Manian, Rossano M. Butcher, Jonathan Ma Levy, Nachiket D. Pendse, Erin Hennessey, David R. Liu, Eric A. Pierce, Qin Liu, Jason Comander · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Global quantification of off-target activity by base editors
    Michelle Eidelman, Eli Eisenberg, Erez Y. Levanon · 2024 · Methods in enzymology on CD-ROM/Methods in enzymology
  48. Precise Mapping of Physiological DSBs Using In-Suspension Break Labeling In Situ and Sequencing (sBLISS)
    Osama Hidmi, Sara K. Oster, Diala Shatleh, Jonathan Monin, Rami I. Aqeilan · 2025 · Methods in molecular biology
  49. Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Lucrezia della Volpe, Roberta Vacca, Raffaella Di Micco · 2025 · STAR Protocols
  50. Characterizing Nucleic Acid‐, Gene‐, and Cell‐Based Therapeutics with Sequencing Technologies
    Hayley M. Bennett, Ashley Byrne, William Stephenson, Zora D. Modrusan · 2025 · Wiley eBooks
  51. Epigenetic reprogramming in breast cancer: The role of CRISPR-Cas 9
    Ashraf Ahmed Qurtam · 2025 · Bulletin du Cancer
  52. Development of new increased fidelity SpCas9 variants
    Péter István Kulcsár · 2019
  53. CRISPR Therapies for Alzheimer’s Disease
    Jichao Sun, Subhojit Roy · 2025 · Springer eBooks
  54. Off-target sequence variations driven by the intrinsic properties of the Cas–sgRNA–DNA complex in genome editing
    Celine Kurniawan, Takeshi Itoh · 2025 · PLoS ONE
  55. 3′-end ligation sequencing is a sensitive method to detect DNA nicks at potential sites of off-target activity induced by prime editors
    Jacob Stewart-Ornstein, Matthew J. Irby, Marina Korinne Lilieholm, Dylan Laprise, Maria Donaldson Collier, Thomas R. Aunins, Dewi Harjanto, Aaron N. Chang, Deepak Reyon, Jeremy S. Duffield · 2025 · Genome Research
  56. Weighted Off-target and Efficiency Scoring Reveal Genome Composition-Dependent Optimal CRISPR/Cas9 Guide Design
    Y K Yathu Krishna · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  57. An integrated enzymatic and computational pipeline for quantifying off-target base-editing
    Alexander G. McFarland, Soon‐Keat Ooi, Davin Tafuri, Elahe Kamali Ghahe, Natalie Cooper, Emma J. Cook, Shantan G. Reddy, Danuta Jadwiga Jarocha, Nils Wellhausen, Saar I. Gill et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Genome Editing as Genetic Engineering Tool: Potential Applications in Production of Microbial Foods for Food Security
    Oluwafemi S. Obayori, Oluwaseun Oyetunji Olasunkanmi · 2025 · Springer eBooks
  59. CRISPR System and AI Applications
    Muhammad Nabeel Asim, Sheraz Ahmed, Andreas Dengel · 2025 · Springer eBooks
  60. Multilevel characterization of genome editor nuclease activity with BreakTag
    Gabriel M. C. Longo, Sergi Sayols, Vassilis Roukos · 2025 · Nature Protocols
  61. Search-and-remove genome editing allows selection of cells by DNA sequence
    Luise Fast, Madina Omar, Philipp Kanis, Theresa Schaffer, Deepika T. Chowdhury, Eva Rakava, Svante Pääbo, Stephan Riesenberg · 2025 · Nature Communications
  62. Additional file 4 of Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
    Jeonghun Kwon, Kim, Minyoung, Hwang, Woochang, Anna Jo, Hwang, Gue-Ho, Jung, Minhee, Kim, Un Gi, Gang Cui, Heon Seok Kim, Eom, Joon-Ho et al. · 2023 · Figshare
  63. Additional file 2 of ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
    Camilo Ayala Breton, Peter Clark, Wang, Lili, Jenny A. Greig, James M. Wilson · 2020 · Figshare
  64. Additional file 1 of ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
    Camilo Ayala Breton, Clark, Peter M., Wang, Lili, Jenny A. Greig, James M. Wilson · 2020 · Figshare
  65. Additional file 3 of ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing
    Camilo Ayala Breton, Peter Clark, Wang, Lili, Jenny A. Greig, James M. Wilson · 2020 · Figshare
  66. Additional file 2 of CasKAS: direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping
    Georgi K. Marinov, Samuel H. Kim, S. Tansu Bagdatli, Soon Il Higashino, Alexandro E. Trevino, Josh Tycko, Tong Wu, Lacramioara Bintu, Michael Cory Bassik, Chuan He et al. · 2023 · Figshare
  67. Additional file 1 of CasKAS: direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping
    Georgi K. Marinov, Samuel H. Kim, S. Tansu Bagdatli, Soon Il Higashino, Alexandro E. Trevino, Josh Tycko, Tong Wu, Lacramioara Bintu, Michael Cory Bassik, Chuan He et al. · 2023 · Figshare
  68. Additional file 1 of CRISPR-KRISPR: a method to identify on-target and random insertion of donor DNAs and their characterization in knock-in mice
    Tanaka, Masayuki, Yokoyama, Keiko, Hayashi, Hideki, Sanae Isaki, Kanae Kitatani, Wang, Ting, Hisako Kawata, Hideyuki Matsuzawa, Gurumurthy, Channabasavaiah B., Hiromi Miura et al. · 2022 · Figshare
  69. Additional file 1 of Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
    Jeonghun Kwon, Kim, Minyoung, Hwang, Woochang, Anna Jo, Hwang, Gue-Ho, Jung, Minhee, Kim, Un Gi, Gang Cui, Heon Seok Kim, Eom, Joon-Ho et al. · 2023 · Figshare
  70. Additional file 1 of Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
    Ida Höijer, Josefin Johansson, Sanna Gudmundsson, Chin, Chen-Shan, Ignas Bunikis, Susana Häggqvist, Anastasia Emmanouilidou, Maria Wilbe, Marcel den Hoed, Bondeson, Marie-Louise et al. · 2020 · Figshare
  71. Additional file 2 of CRISPR-KRISPR: a method to identify on-target and random insertion of donor DNAs and their characterization in knock-in mice
    Tanaka, Masayuki, Yokoyama, Keiko, Hayashi, Hideki, Sanae Isaki, Kanae Kitatani, Wang, Ting, Hisako Kawata, Hideyuki Matsuzawa, Gurumurthy, Channabasavaiah B., Hiromi Miura et al. · 2022 · Figshare
  72. Additional file 6 of Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
    Jeonghun Kwon, Kim, Minyoung, Hwang, Woochang, Anna Jo, Hwang, Gue-Ho, Jung, Minhee, Kim, Un Gi, Gang Cui, Heon Seok Kim, Eom, Joon-Ho et al. · 2023 · Figshare
  73. Additional file 3 of Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
    Jeonghun Kwon, Kim, Minyoung, Woo Chang Hwang, Anna Jo, Hwang, Gue-Ho, Jung, Minhee, Kim, Un Gi, Gang Cui, Heon Seok Kim, Eom, Joon-Ho et al. · 2023 · Figshare
  74. Additional file 13 of Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity
    Ida Höijer, Josefin Johansson, Sanna Gudmundsson, Chin, Chen-Shan, Ignas Bunikis, Susana Häggqvist, Anastasia Emmanouilidou, Maria Wilbe, Marcel den Hoed, Bondeson, Marie-Louise et al. · 2020 · Figshare
  75. Genome Editing Technologies in Precision Medicine
    Kazi Asraf Ali, Rideb Chakraborty, Naureen Afrose, Chowdhury Mobaswar Hossain, Amit Kotal, Sourav Samanta · 2026 · IGI Global eBooks
  76. DNA-free genome editing in Solanaceae: an evidence-based roadmap from transformation to field and regulatory readiness
    Ying Qin, Wenwen Si, Chengchuang Huang · 2026 · Plant Biotechnology Reports
  77. CRISPR-Cas9: Genome Engineering and Future Vaccine Applications
    Masoumeh Madhi, Pourya Gholizadeh · 2026 · Molecular Biotechnology
  78. Tracking-seq: a universal off-target detection approach for CRISPR–Cas genome editing
    Runda Xu, Tingting Cong, Junsong Yuan, Xuancheng Chen, Yinqing Li, Xun Lan, Ming Zhu · 2026 · Nature Protocols
  79. Recombinant Adeno-Associated Viruses : process development and gene transfer application for muscular dystrophy
    Gabriella Dias Florencio Leite · 2017
  80. Decoding DNA metabolism and its clinical relevance through the lens of high-throughput sequencing assays
    Jingzhi Luo, Fanyu Zhao, Shuyan Lin, Yang Liu · 2026 · Medical Review
  81. Etudes des translocations chromosomiques en utilisant les méthodes d'édition du génome : des mécanismes moléculaires à l’oncogenèse
    Loélia Babin · 2019
  82. Gene editing approaches of microsatellite disorders : shortening expanded repeats
    Lucie Poggi · 2020 · theses.fr (ABES)
  83. Integrating Experimental Assays, Preclinical Models, and CRISPR-Based Functional Approaches for Cancer Drug Discovery
    Cromwel Tepap Zemnou, Ramelle Ngakam · 2026 · Cell Biochemistry and Biophysics
  84. CRISPR-Cas9-based strategies for enhanced targeted integration
    Laurie Lacombe · 2024
  85. CRISPR-Cas9 off-target effects in urothelial gene therapy: the overlooked risk of P53 mutational signatures in bladder tissue
    Sedaghat Dyl Zahra, Azan Ahmed, Vareesha Batool, Abdul Haseeb Hasan · 2026 · Annals of Medicine and Surgery
  86. Gene therapy for liver diseases: methods, challenges and opportunities
    Mengyao Yan, Qian Xiang · 2026 · Journal of Nanobiotechnology
  87. Compact Cas12f enables genome editing in avian cells
    Yujin Han, Seung Je Woo, Heesun Choi, Jae Yong Han · 2026 · Poultry Science
  88. intmap: fast and flexible mapping of mobile DNA integration for basic and translational research
    Gregory J. Bedwell, P.G. Cherepanov, Alan Engelman · 2026 · Bioinformatics
  89. Leveraging CRISPR/Cas9 for optimized adoptive T cell therapies: From molecular engineering to clinical manufacturing
    Ji-Hyeon Kim, Hyo Jung Cho, Hyang‐Mi Lee · 2026 · Biochemical and Biophysical Research Communications
  90. Connexin 26 in Hearing Health and Disease: StructuralFoundations, Mutation Mechanisms, and Therapeutic Perspectives
    Weihua Qiu, Kaelah Schneider, Youzhong Guo · 2026 · International Journal of Molecular Sciences
  91. CRISPR-Cas-Based Editing Technologies in Preclinical Models for Disease Correction
    Prakriti Karki, Sudarshan GC · 2026 · Genetics.
  92. CRISPR-MBTF: a multi-branch transformer fusion framework for CRISPR-Cas9 off-target prediction
    Ali Jahangiri-Sisakht, Leila Safari, Roghayyeh Alipanahi · 2026 · Briefings in Bioinformatics
  93. Systematic profiling of PE6 variants establishes generalizable principles for efficient and specific prime editing
    Kyuwon Shin, Ju-Young Shin, Aram Woo, Dabin Han, Beomjun Lee, Hui Kwon Kim · 2026 · Research Square
  94. EHNN: enhanced hybrid neural network for CRISPR-Cas9 gRNA off-target prediction
    Akhtar Sayed, Kifayat Ullah, Muzammil Khan, Rayed A. Alakhtar, Huda Alsobhi · 2026 · PeerJ Computer Science
  95. Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes
    Zahid Yaseen, M. Mothilal · 2026 · Stem Cell Reviews and Reports
  96. In vivo immune cell engineering from bench to clinical reality
    Hui Yu, Maosen Han, Xiaotian Zhao, Chunwei Tang, Yanda Jia, Weiqiang Jing, Xinyi Jiang · 2026 · Pharmaceutical Science Advances
  97. abCRISPR: deep learning-based design of abasic gRNA sequences for specific CRISPR-Cas9 genome editing
    Geun-Woo D. Kim, Dowoon Gu, Mingyo Park, Sung Wook Chi · 2026 · Bioinformatics
  98. Gene therapy for genodermatoses at the crossroads of innovation and clinical translation
    Alessandra Fabrizi, Marta Valenti, SILVIA ZACCHINO, Katia Russo, Erica Baschetti, Laura De Rosa, Michele De Luca · 2026 · Frontiers in Bioengineering and Biotechnology
  99. Machine learning approaches in gene editing
    Mohamed A. M. Atia, Abdelghani Belgaid, Kamel A. Abd-Elsalam, Achraf El Allali · 2026 · Elsevier eBooks
  100. CRISPGen: A deep generative framework for multi-objective CRISPR/Cas9 guide RNA design via Conditional Latent Diffusion and Dual-Critic Reinforcement Learning
    Mohammad Malekpouri, Somayeh Lotfi · 2026 · Computational Biology and Chemistry